ArchiveAt present, high-risk factors for cardiovascular disease such as hypertension and dyslipidemia have been effectively managed, but cardiovascular diseases remain the main cause of disability and mortality worldwide. Aging is an inevitable process in human life, and the cardiovascular system is no exception. Cardiovascular aging is closely related to an increased risk of cardiovascular diseases. Exploring the mechanisms of cardiovascular aging is of great significance for the treatment of cardiovascular diseases, drug development, and improvement of patient prognosis. This article reviewed the mechanism of cardiovascular aging, in order to provide reference for future research.
The cardiovascular system operates under continuous mechanical and metabolic pressure, and as age increases, the risk of functional impairment at the molecular, cellular, and organ levels gradually increases. Especially with impaired macroautophagy function and epigenetic changes, including DNA methylation, histone modifications, and non-coding RNA. These cardiovascular aging mechanisms are closely intertwined, and the strengthening or weakening of individual mechanisms can affect other mechanisms. Understanding these cardiovascular aging mechanisms is expected to provide new ideas and directions for the diagnosis of cardiovascular diseases and the development of new drugs in the future.
To observe and compare the effects of Yuanhu Zhitong dropping pill and ibuprofen on pain and anxiety in patients with primary dysmenorrhea (PD).
Eighty patients with PD in the obstetrics and gynecology outpatient department of Shanggang community health service center from January to December 2023 were selected and randomly divided into the Yuanhu Zhitong dropping pill group and the ibuprofen group, with 40 patients in each group. The Yuanhu Zhitong dropping pill group was given oral administration of Yuanhu Zhitong dropping pill and the ibuprofen group was given oral ibuprofen for three consecutive days starting from the first day of menstruation for a total of five menstrual cycles. Visual analogue score (VAS), pain time and Hamilton anxiety scale were used to compare the pain and anxiety status of the two groups before, after treatment and the follow-up period.
Compared with before treatment, the pain scores, pain duration and anxiety scores of patients in Yuanhu Zhitong dropping pill group and ibuprofen group significantly improved after treatment and during the follow-up period (P<0.001). The comparison between the two groups showed that after treatment and during follow-up, the pain score, pain duration, and anxiety score in the ibuprofen group were significantly lower than those in the Yuanhu Zhitong dropping pill group (P<0.001).
Both Yuanhu Zhitong dropping pill and ibuprofen can effectively reduce pain and improve anxiety in patients with PD, and ibuprofen is more effective than Yuanhu Zhitong dropping pill for pain episodes.
To investigate the effects of Mashe Anjin pill combined with acetylcysteine nebulization inhalation therapy on sputum viscosity and oxygen metabolism in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
A total of 120 AECOPD patients admitted to our hospital from July 2021 to October 2023 were included and randomly divided into western medicine group and combination group by random number table method, with 60 cases in each group. The western medicine group was given acetylcysteine nebulization inhalation on the basis of conventional treatment, while the combination group was given oral administration of Mashe Anjin pill based on western medicine group. Both groups received continuous treatment for 14 days. The changes in sputum viscosity, blood gas analysis indexes [partial pressure of carbon dioxide (PaCO2), arterial oxygen pressure (PaO2) and oxygen saturation (SaO2)], pulmonary ventilation function indicators [forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1/FVC] in both groups were measured and recorded before and after treatment, and the clinical efficacy of each group was observed and compared.
After treatment, the total effective rate of the western medicine group was lower than the combination group (75.00% vs 93.33%, P<0.05). The viscosity of sputum in both groups improved, and the improvement degree in the combination group was obviously better than that in the western medicine group (P<0.05). After treatment, the SaO2 and PaO2 in both groups were increased than before treatment (P<0.05), while the PaCO2 was decreased (P<0.05), and the SaO2 and PaO2 in the combination group were higher than the western medicine group (P<0.05), while the PaCO2 was lower than the western medicine group (P<0.05). After treatment, the FVC, FEV1, and FEV1/FVC of both groups were increased than before treatment (P<0.05), and the combination group were higher than the western medicine group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
The combination of Mashe Anjin pill and acetylcysteine nebulization inhalation can effectively reduce sputum viscosity, improve oxygen metabolism and lung ventilation function, and improve clinical efficacy in AECOPD patients.
To investigate the curative effect of Shugan Hewei Jiangni decoction combined with herb-separated moxibustion on navel in the treatment of reflux esophagitis (RE) patients with liver and stomach dishonant syndrome.
A total of 112 cases of RE patients with liver and stomach disordered syndrome admitted to our hospital from September 2019 to September 2020 were selected and divided into control group (routine+herb-separated moxibustion on navel) and research group (routine+herb-separated moxibustion on navel+Shugan Hewei Jiangni decoction), with 56 cases in each group. The clinical efficacy, gastrointestinal hormone levels, gastrointestinal dynamics indexes, serum inflammatory factor levels before and after treatment and 6-month recurrence rate were compared between the two groups.
After treatment, the total effective rate of the study group (94.64%) was higher than that of the control group (82.14%)(P=0.039). Compared with the control group, the levels of traditional Chinese medicine symptom score, serum cholecystokinin, vasoactive intestinal peptide, 5-hydroxytryptamine, C-reactive protein, tumor necrosis factor-α and interleukin-1β were significantly decreased in the study group (P<0.05), but the levels of gastrin, motilin and somatostatin were significantly increased (P<0.05). The 6 months recurrence rate of the study group (1.79%) was lower than that of the control group (16.07%)(P<0.05).
Shugan Hewei Jiangni decoction combined with herb-separated moxibustion on navel can effectively improve the clinical symptoms, regulate gastrointestinal hormone levels, improve gastric dynamics, regulate serum inflammatory factors and reduce the recurrence rate of patients with liver and stomach dishonant syndrome RE.
To explore the effects of meropenem combined with probiotics on inflammatory response and intestinal mucosal barrier function in patients with spontaneous bacterial peritonitis (SBP) caused by liver cirrhosis.
A total of 102 patients with cirrhosis complicated with SBP who were treated in Jing-an district central hospital from January 2021 to March 2023 were selected as the study objects, and were divided into 52 cases in the control group (meropenem treatment) and 50 cases in the study group (meropenem combined with bifidobacterium triactive enteric capsule treatment). The curative effect, inflammatory factor levels, intestinal mucosal barrier function, and adverse reactions before and after the treatment were compared between the two groups.
The total effective rate of the study group (94.00%) was significantly higher than that of the control group (78.85%)(P<0.05). After treatment, the levels of inflammatory factors, diamine oxidase, D-lactic acid and the ratio of urinary lactulose excretion rate to mannitol excretion rate were decreased in two groups (P<0.05), and the decrease was more significant in the study group than in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
Probiotics combined with meropenem can effectively improve the clinical efficacy of cirrhosis complicated with SBP, inhibit the secretion of inflammatory factors, improve the intestinal mucosal barrier function of patients, and have a high safety.
To observe the effects of Yiqi Yangyin Qufeng recipe on inflammatory factors and oxidative stress in patients with type 2 diabetic nephropathy (DN).
A total of 60 patients with type 2 DN admitted to nephrology departments of outpatient and inpatient of our hospital from January 2022 to June 2023 were included and randomly divided into treatment group and control group, with 30 cases in each group. All patients were given lifestyle guidance to control blood glucose, blood lipids, etc. The treatment group was also given Yiqi Yangyin Qufeng recipe, and the control group was also given valsartan. The treatment course was 12 weeks. Traditional Chinese medicine (TCM) syndrome score, clinical efficacy, serum creatinine (Scr), urinary albumin/creatinine (UACR), peripheral blood mononuclear cell nuclear factor (NF)-κBP65, urinary monocyte chemotactic stimulating factor (UMCP)-1, interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α, highly sensitive C-reactive protein (hs-CRP), superoxide dismutase (SOD), and serum malondialdehyde (MDA) levels were observed and compared between the two groups before and after treatment.
The total effective rate of the treatment group was higher than that of the control group (86.67% vs 63.33%, P<0.05). The treatment group was superior to the control group in improving the levels of TCM syndrome score, UACR, NF-κBP65, TNF-α, IL-1, IL-6, SOD, MDA and UMCP-1 (P<0.05), and there were no significant differences in the levels of Scr and hs-CRP between the two groups (P>0.05). Correlation analysis showed that NF-κBp65 was positively correlated with UMCP-1 (r=0.562 1, P<0.05).
Yiqi Yangyin Qufeng recipe can reduce the expression level of inflammatory factors and inhibit oxidative stress in type 2 DN patients, which can be regarded as one of the effective drugs for type 2 DN.
To explore the correlation between blood magnesium level in patients with maintenance hemodialysis (MHD) and cardiovascular events and all-cause death.
The clinical data of 122 patients treated with MHD in our hospital from January 2021 to January 2023 were retrospectively analyzed, and the patients were divided into high magnesium group (blood magnesium≥0.93 mmol/L, n=67) and low magnesium group (blood magnesium<0.93 mmol/L, n=55) according to the median blood magnesium level. Kaplan-Meier survival curve was used to compare the cumulative survival rate of the two groups, and Cox regression model was used to analyze the risk factors of all-cause death.
The levels of serum albumin, prealbumin, magnesium, phosphorus and C-reactive protein were significantly different between the two groups (P<0.05). The incidence of cardiovascular events and all-cause mortality in low magnesium group were higher than those in high magnesium group (P<0.05). The cumulative survival rate of low magnesium group was significantly lower than that of high magnesium group (P<0.01). Univariate Cox regression analysis showed that hypomagnesium was a risk factor for cardiovascular events and all-cause death (P<0.01). After multifactor correction, hypomagnesium was an independent risk factor for cardiovascular events, but not an independent risk factor for all-cause death (P>0.05).
MHD patients with low blood magnesium levels have a higher incidence of cardiovascular events and an increased risk of all-cause death.
To evaluate the efficacy and safety of muscovite-infused blood circulation and blood stasis ointment in the treatment of knee osteoarthritis (KOA).
A total of 1 600 KOA patients treated in orthopedics and traumatology departments of 11 hospitals across the country from September 2020 to December 2022 were selected and randomly divided into experimental group (n=1 200, treated with muscovite-infused blood circulation and blood stasis ointment) and control group (n=400, treated with diclofenac diethylamine emulgel) according to a ratio of 3∶1. The course of treatment in both groups was 14 days. Western Ontario and McMaster universities arthritis index (WOMAC) score, visual analogue scale (VAS), traditional Chinese medicine (TCM) syndrome score scale and knee swelling scale score, etc., and the occurrence of adverse reactions were observed in both groups.
The total effective rate of the experimental group was higher than that of the control group (86.75% vs 76.50%, P<0.05). The scores of WOMAC, VAS, TCM syndrome score scale and knee swelling scale in both groups were significantly improved, and the improvement of TCM syndrome score scale and knee swelling scale in the experimental group were better than those in the control group (P<0.05). During the treatment period, there were no adverse reactions such as drug poisoning or liver and kidney function injury in both groups.
Muscovite-infused blood circulation and blood stasis ointment can effectively improve the clinical symptoms of KOA patients, with accurate effect and high safety.
To investigate the effect of roxallistat assisted erythropoietin (EPO) on patients with renal anemia (RA) and its effect on transferrin (TRF) and TRF saturation (TSAT) levels.
A total of 179 RA patients treated in the department of nephrology, Mingguang people's hospital from January 2021 to December 2023 were selected and divided into experimental group (n=90, EPO+roxallistat) and control group (n=89, EPO) by random number table method. Both groups were treated for 12 months. The clinical efficacy, TRF, TSAT, serum indexes of anemia [red blood cell (RBC), hemoglobin (Hb), serum ferritin (SF)] and the incidence of adverse reactions were compared between the two groups.
After treatment, the clinical effective rate of experimental group was higher than that of control group (91.11% vs 79.78%, P<0.05). The levels of TRF, TSAT, RBC, Hb and SF in both groups were higher than before (P<0.05), and the experimental group was higher than the control group (P<0.05). The incidence of adverse reactions in experimental group and control group was 6.67% and 10.11%, respectively, with no significant difference (P>0.05).
Roxallistat assisted EPO in the treatment of RA is effective, and can improve the level of TRF, TSAT and anemia.
To investigate the effect of combination therapy with baritinib in the treatment of rheumatoid arthritis (RA) and influence of internal circulation state and bone metabolism.
A total of 199 RA patients treated in our hospital from January 2021 to December 2023 were selected and divided into observation group (n=100) and control group (n=99) by random number table method. The control group was treated with eramod combined with methotrexate, and the observation group was treated with baritinib on the basis of the control group, the course of treatment was 90 days. The curative effect, peak systolic velocity (PSV), peak diastolic velocity (PDV), vascular resistance, serum osteocalcin (OC), 25-hydroxyvitamin D, β-collagen degradation product (CTX), total type Ⅰ collagen amino terminal lengthening peptide (PINP), morning stiffness time, number of joint tenderness, number of joint swelling, visual analogue scale (VAS) score and incidence of adverse reactions were compared between the two groups.
After treatment, the total effective rate of observation group was higher than that of control group (91.00% vs 79.80%, P<0.05). PSV, PDV, OC, 25-hydroxyvitamin D and PINP in both groups were higher than before, and observation group was higher than control group (P<0.05). Vascular resistance, β-CTX, morning stiffness time, number of joint tenderness, number of joint swelling and VAS score in both groups were decreased, and the observation group was lower than the control group (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).
Combination therapy with baritinib has a good effect in the adjuvant treatment of RA, and can improve the internal circulation status and bone metabolism level of patients to a certain extent.
To investigate the risk factors of brain injury in high-risk infants in neonatal intensive care unit (NICU).
A total of 655 high-risk NICU infants admitted to the second people's hospital of Wuhu from March 2019 to March 2023 were selected as the study objects, which were divided into brain injury group (n=131) and no brain injury group (n=524) according to whether brain injury occurred. Baseline data, fetal distress in uterus (FDIU), mode of delivery, mechanical ventilation (MV), assisted fertility technologies, brain-derived neurotrophic factor (BDNF), 25 hydroxyvitamin D[25(OH)D] were monitored and recorded. Univariate analysis and logistic regression analysis were used to analyze the risk factors of brain injury in NICU high-risk infants.
Compared with no brain injury group, the number of low body mass cases, FDIU cases, MV cases, prenatal risk factors, maternal infection, BDNF and 25(OH)D levels in brain injury group were higher (P<0.05). Logistic regression analysis showed that low body weight, FDIU, MV, prenatal risk factors, maternal infection, BDNF, 25(OH)D were risk factors for brain injury in NICU high-risk infants (P<0.05).
Low body mass, FDIU, MV, prenatal risk factors, maternal infection, BDNF, 25(OH)D were risk factors for brain injury in NICU high-risk infants. On the basis of considering the above factors, targeted interventions can be taken in clinic to help reduce the risk of brain injury.
In recent years, the incidence rate of atopic dermatitis (AD) has gradually increased, especially the incidence rate of AD and the proportion of severe patients in children. AD patients have obvious clinical itching symptoms, and are prone to recurrent episodes, which seriously affects the quality of life of patients and their families. In clinical practice, accurately understanding the changes in the severity of AD patients during the diagnosis and treatment is helpful to timely adjust clinical medication and treatment plans. Therefore, it is crucial to conduct standardized assessment and long-term management of the severity of skin lesions in AD patients. Currently, there are over 60 assessment tools for the severity of AD skin lesions in clinical practice, including those based on physician evaluations and patient subjective perceptions. This article systematically sorted out the usage methods, advantages and disadvantages of commonly used assessment tools based on the latest version of the national and international expert consensus, in order to facilitate clinical staff to better choose and use these assessment tools.
Non-alcoholic fatty liver disease (NAFLD) is a growing health problem worldwide, and epithelial-mesenchymal transition (EMT) plays a central role in the fibrotic progression of NAFLD. This paper reviewed the mechanism of EMT-related action in NAFLD in recent years, including transforming growth factor-β, micro RNA and extracellular vesicles, which play an important role in regulating the interaction between liver cells and fibrosis process. It provides a direction for researchers for the development of new therapeutic strategies and the research for new biomarkers for NAFLD, especially targeted interventions targeting the EMT process and its related molecules and signaling pathways, which may provide effective means to slow down or reverse fibrosis.
Sinomenine is an alkaloid monomer extracted from Caulis Sinomenii. Sinomenine was initially known for its anti-inflammatory and immunosuppression, and is mainly used in the treatment of rheumatoid arthritis (RA) and autoimmune diseases. In recent years, sinomenine have been found that it could also play an anti-breast cancer (BC) role through a variety of mechanisms, and less adverse reactions. This article reviewed the mechanism of sinomenine in the treatment of BC, in order to in order to promote the development of more studies of sinomenine in anti-tumor aspects, and provide a theoretical basis for its use in the treatment of BC.
To evaluate the cost-utility of eculizumab versus supportive therapy in the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
From the perspective of whole Chinese society, a partitioned survival model was constructed to simulate the total cost, quality-adjusted life years (QALYs) and incremental cost-effectiveness ratio (ICER) of patients over a lifetime (40 years) with a discount rate of 5%. One-way sensitivity analysis and probabilistic sensitivity analysis were used to verify the robustness of the model.
The base-case results showed that compared with supportive therapy, patients who used eculizumab could obtaine 8.50 more QALYs and an incremental cost of 639 784 CNY, the ICER was 75 297 CNY/QALY, which was lower than the GDP per capita in 2023. The one-way sensitivity analysis showed that the annual spontaneous remission rate had the most significant impact on the final result. The probabilistic sensitivity analysis showed that the probability of cost-effective of eculizumab was 99.98% when the willingness-to-pay threshold was 3 times of GDP per capital.
From the perspective of the Chinese society, eculizumab was a cost-effective treatment regimen compared to supportive therapy in the treatment of PNH patients.